Navigation Links
Poll Shows Voters Want Long Term Care Included in Presidential Candidates' Healthcare Proposals, Released at 2007 National Long Term Care Symposium
Date:10/11/2007

challenges of long term care. As of Monday, it will be available at-cost for less than $10 per copy on Amazon.com and other popular websites that sell books.

The book is comprised of ten chapters, each written by a different author such as AARP CEO Bill Novelli, former Congressional Budget Office Director Douglas Holtz-Eakin, American Health Care Association President and CEO Bruce Yarwood and National Alliance for Caregivers President and CEO Gail Hunt. It covers a wide range of long term care issues including the role of technology in future care, Alzheimer's disease, independent living, public funding for long term care programs, the growing demand and delivery (home-based and facility-based) of long term care services and other relevant topics. More information about the book, including a full list of chapters and their authors, can be found at Genworth.com.

"We commissioned this non-profit book with the goal of providing the authors an open forum to lay out their views and recommendations on how we should provide, fund and improve our long term care system," said Stinson. "It was important to us to give these distinguished authors a platform to freely express their opinions, independent of our positions, so we could provide the public with this valuable information and help policy makers and consumers make informed decisions."

About Genworth Financial

Genworth is a leading financial security company meeting the retirement, longevity and lifestyle protection, investment and mortgage insurance needs of more than 15 million customers, with a presence in more than 25 countries. For more information, visit Genworth.com.


'/>"/>
SOURCE Genworth Financial, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. Gene Therapy shows promise in treating Hemophilia
3. New Prostate Cancer Vaccine Shows Promise
4. Leukemia pill shows promise against stomach cancer
5. Stent shows promise in keeping arteries open
6. Drug to treat lung cancer shows promise
7. Latest drug shows promise in multiple myeloma
8. AIDS vaccine falls short but shows some promise
9. Ebola Treatment Shows Promise
10. SARS vaccine shows promise in Animal Testing
11. New Drug Shows Significant Improvement In HIV-related Heart Condition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...erville-based civil litigation and criminal defens...after jury awarded $3.2 million to plaintiff earli...e, Maryland ((Lexis Nexis) October 6, 2008 -- Atto...[Miller, Murtha & Psoras] have successfully re... Maryland welder who was awarded more than $3 mill...
(Date:10/5/2008)...ore healthy choices at schools, standard offerings...e giving students more calories than they need. ,...ide effort led by Temple University to curb obesit...ound vending machines beverages had added sugars, ...over 200 hundred calories. , The data will be pr...
(Date:10/5/2008)...cription drug samples distributed to children may ... Cambridge Health Alliance and Hasbro Children,s H...free drug sample use among children, appears in th...hors, who also serve as researchers at Harvard Med...f Brown University, found that children commonly r...
(Date:10/5/2008)...ized kids with painful ailments from broken bones ... drugs known as opiates. The medications block pai...ion, for instance, is one side effect that can cau...stay. , "No parent wants their child in the hosp... MD, MPH, medical director for quality management ...
Breaking Medicine News(10 mins):Health News:Miller, Murtha & Psoras Secures Multimillion-Dollar Settlement for Victim of Industrial Accident at Bethlehem Steel 2Health News:School vending machines dole out excess calories, fat 2Health News:Free drug samples carry risks for children 2Health News:Major study of opiate use in children's hospitals provides simple steps to alleviate harm 2Health News:Major study of opiate use in children's hospitals provides simple steps to alleviate harm 3
...s that the risk of depression increases in women w...ls who are insulin-resistant may have higher serot...ression and even suicide. Researchers say Insu...with depression and that their results are consist...
...als that a tonsillectomy procedure using less ener... to reducing pain during recovery. // During a to...cial scalpel heats tissue as it goes along to cont...e microdissection needle technique uses less energ...
...s a vaccine made from the common cold virus may in...s.//Researchers from the Centers for Disease Contr...tically altered cold virus that is similar to part...ronavirus, called SARS-CoV, was discovered earlier...
...ws taking vitamin D and consuming a diet high in f...t can lead to colon cancer.// Researchers from 13...n 3,100 patients between ages 50 and 75. Results o...e than four grams of cereal fiber per day and more...
Other Medicine News:Health News:Preventing Colorectal Cancer 2
(Date:10/6/2008)...ntific Conference -, ORLANDO, Fla., Oct. 6 /PRNew...bia) today announced presentation of data from a p...at cyclic guanosine,monophosphate (cGMP) plays in ...rate that cGMP inhibits intestinal pain in a precl...itizes colonic afferent nerves in a,similar model ...
(Date:10/6/2008)...py is More Likely to Induce Steroid-Free Remissi... Immunomodulator, Azathioprine, OR... for the first time,from the Phase 3b Study of Pat...rs and Biologic Therapy (SONIC) may provide new in...moderate to severe Crohn,s disease.,According to f...
(Date:10/6/2008)...Naltrexone SR Associated with Bette.... 6 /- Orexigen Therapeutic...any focused on the treatment of,obesity and other ...esented,data showing the investigational drug, Con...lly achieved key objectives (lowered naltrexone,Cm...
(Date:10/5/2008)...f Medicine reaffirm,well-established efficacy and ...R), RIDGEFIELD, Conn., and NEW YORK, Oct. 5 /PRNe...tential Long-term Impacts on Function with,Tiotrop...tiotropium bromide,inhalation powder), sustained i...measured by FEV(1) (p<0.001) versus placebo in Chr...
Breaking Medicine Technology:Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 2Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6Delivering Molecular Imaging Solutions Across Clinical Specialties 3A Siemens Showcases New Technologies at RSNA 2007 1871 1Delivering Molecular Imaging Solutions Across Clinical Specialties 3A Siemens Showcases New Technologies at RSNA 2007 1871 2Delivering Molecular Imaging Solutions Across Clinical Specialties 3A Siemens Showcases New Technologies at RSNA 2007 1871 3Delivering Molecular Imaging Solutions Across Clinical Specialties 3A Siemens Showcases New Technologies at RSNA 2007 1871 4Delivering Molecular Imaging Solutions Across Clinical Specialties 3A Siemens Showcases New Technologies at RSNA 2007 1871 5Regular exercise reduces risk of blood clots 6712 1Evolutionary comparison finds new human genes 1289 1Evolutionary comparison finds new human genes 1289 2Evolutionary comparison finds new human genes 1289 3New book presents methods to poke and prod individual molecules 1284 1New book presents methods to poke and prod individual molecules 1284 2
... -- Novagali Pharma, an,emerging ophthalmic pharma...ounces today positive results from the Phase III,c...from Vernal,Keratoconjunctivitis (VKC). In this or...signs of disease improved in patients,receiving Ve...(R),was excellent. , VKC is a severe form of chron...
...f the International,Society on Thrombosis and Haem...07 /PRNewswire/ --,Portola Pharmaceuticals, Inc. t...ts from EXPERT, a Phase II study of its oral Facto...enous,thromboembolism (VTE) following total knee r...Portola will advance PRT054021,into further clinic...
Other Medicine Technology:Novagali Pharma Announces Positive Vekacia Clinical Results From,Pivotal Phase III Trial in Vernal Keratoconjunctivitis 2Portola Pharmaceuticals Announces Positive Phase II Results for,PRT054021 for Prevention of Venous Thromboembolism Following Total,Knee Replacement Surgery 2Portola Pharmaceuticals Announces Positive Phase II Results for,PRT054021 for Prevention of Venous Thromboembolism Following Total,Knee Replacement Surgery 3
With this unique offer, you can prepare for any molecular biology application. Pipetman P2 and P10 are ideal for enzymes and reagents, and P100 is perfect for buffers. Kits include Diamond Filter Tip
The RapidPCP test is an immunochromatography based one step in vitro test. It is,designed for qualitative determination of Phencyclidine in human urine specimens above,a cut-off level of 25 ng/mL. Th
... an immunochromatography based one step,in vitro t...of Opiates and its metabolite in,human urine speci...e a cut-off level,of 2,000ng/mL can be detected. T...are,location and is for use by Healthcare Professi...
All of DOA Panel Test is an immunochromatography based one step in vitro test. It is designed,for qualitative determination of drug substances in human urine specimens. This assay has not,been evalua
Medicine Products: